RxDoctor Payments Data

William Shaw, NP

Family · Savannah, TNNPI 1881284594

Payments from drug & device makers

$557in general payments, 2019–2025

Across 26 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$136
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$64
  • Hologic Sales And Service, LLC$63
  • Amgen$55
  • AstraZeneca$50
  • Pfizer$43
  • plus $145 from 6 others

What the payments were for

  • Food & beverage$557100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$557 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,994
Medicare patients
44
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$55,372
VraylarCariprazine Hcl17$34,055
JardianceEmpagliflozin27$28,594
FarxigaDapagliflozin Propanediol25$22,525
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$20,671
MounjaroTirzepatide16$16,768
RybelsusSemaglutide11$13,725
EliquisApixaban15$12,941
MyrbetriqMirabegron20$10,551
Bydureon BciseExenatide Microspheres12$9,961
LinzessLinaclotide17$9,637
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,294
BrilintaTicagrelor12$5,093
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$2,150
Gabapentin110$1,698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$21$69,09854 claims
AbbVieVraylar, Linzess$136$43,69134 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$50$35,91351 claims
GSKTrelegy Ellipta$13$20,67130 claims
PfizerEliquis$43$12,94115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Savannah

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →